Skip to content
Savara Inc icon

Savara Inc

SVRAStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$5.07

Today

+1.4%

YTD

-15.7%

About

Savara, Inc. is a clinical stage biopharmaceutical company. Specialising in novel therapeutic development and research, Savara operates globally. Involved in the healthcare sector, Savara’s focus lies within biotech and pharmaceutical services, primarily in rare disease research. Its services encompass development, research, and commercialisation of treatments that offer a better quality of life for patients suffering from rare respiratory illnesses. Savara’s target market is very specific, solely focusing on rare respiratory conditions that require innovative and targeted solutions. Stay up to date on the share price of SVRA by adding it to your eToro. watchlist.

Price chart
Closing price history for SVRA (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-10.80
P/S (TTM)0.00
P/B (TTM)7.02
Market cap$1.24B
Cap tierSmall-cap
Industry avg P/E-43.36

Profitability

Gross marginUnknown
EBIT margin0.00%
Net marginUnknown
ROE-79.95%
ROA-63.01%

Earnings & Revenue

Revenue (TTM)$0.00
Revenue growth (1Y)Unknown
EPS (TTM)-$0.56
Free cash flow$-106.97M
Total debt$30.11M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.07
Employees70
Next earnings11 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.